State of Alaska Department of Revenue’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$659K Buy
10,116
+920
+10% +$59.9K 0.01% 1252
2025
Q1
$615K Sell
9,196
-216
-2% -$14.4K 0.01% 1269
2024
Q4
$520K Sell
9,412
-55
-0.6% -$3.04K 0.01% 1371
2024
Q3
$564K Buy
9,467
+464
+5% +$27.6K 0.01% 1366
2024
Q2
$573K Sell
9,003
-181
-2% -$11.5K 0.01% 1307
2024
Q1
$634K Sell
9,184
-744
-7% -$51.4K 0.01% 1265
2023
Q4
$547K Sell
9,928
-47
-0.5% -$2.59K 0.01% 1320
2023
Q3
$579K Buy
9,975
+813
+9% +$47.2K 0.01% 1249
2023
Q2
$493K Buy
9,162
+796
+10% +$42.8K 0.01% 1370
2023
Q1
$332K Sell
8,366
-141
-2% -$5.6K ﹤0.01% 1512
2022
Q4
$342K Buy
8,507
+148
+2% +$5.95K ﹤0.01% 1504
2022
Q3
$268K Sell
8,359
-807
-9% -$25.9K ﹤0.01% 1543
2022
Q2
$271K Buy
9,166
+320
+4% +$9.46K ﹤0.01% 1551
2022
Q1
$248K Buy
8,846
+1,180
+15% +$33.1K ﹤0.01% 1566
2021
Q4
$353K Buy
7,666
+475
+7% +$21.9K ﹤0.01% 1563
2021
Q3
$236K Buy
7,191
+322
+5% +$10.6K ﹤0.01% 1605
2021
Q2
$240K Buy
6,869
+350
+5% +$12.2K ﹤0.01% 1596
2021
Q1
$235K Sell
6,519
-970
-13% -$35K ﹤0.01% 1587
2020
Q4
$217K Sell
7,489
-1,463
-16% -$42.4K ﹤0.01% 1576
2020
Q3
$252K Buy
8,952
+230
+3% +$6.48K ﹤0.01% 1481
2020
Q2
$282K Buy
8,722
+100
+1% +$3.23K ﹤0.01% 1462
2020
Q1
$351K Buy
8,622
+1,600
+23% +$65.1K 0.01% 1252
2019
Q4
$433K Sell
7,022
-116
-2% -$7.15K 0.01% 1368
2019
Q3
$520K Buy
7,138
+4,277
+149% +$312K 0.01% 1257
2019
Q2
$235K Buy
2,861
+67
+2% +$5.5K ﹤0.01% 1407
2019
Q1
$197K Buy
2,794
+35
+1% +$2.47K ﹤0.01% 1460
2018
Q4
$124K Sell
2,759
-210
-7% -$9.44K ﹤0.01% 1537
2018
Q3
$167K Hold
2,969
﹤0.01% 1541
2018
Q2
$198K Buy
2,969
+90
+3% +$6K ﹤0.01% 1487
2018
Q1
$167K Buy
2,879
+1,100
+62% +$63.8K ﹤0.01% 1463
2017
Q4
$114K Hold
1,779
﹤0.01% 1481
2017
Q3
$93K Buy
1,779
+190
+12% +$9.93K ﹤0.01% 1196
2017
Q2
$74K Buy
1,589
+709
+81% +$33K 0.01% 1158
2017
Q1
$43K Buy
880
+20
+2% +$977 ﹤0.01% 1139
2016
Q4
$52K Buy
+860
New +$52K 0.01% 829